935
Views
0
CrossRef citations to date
0
Altmetric
Original Research Article

Cost-effectiveness of infant hypoallergenic formulas to manage cow’s milk protein allergy in France

, , ORCID Icon, , , & show all
Article: 2154418 | Received 25 May 2022, Accepted 29 Nov 2022, Published online: 10 Dec 2022

References

  • Hansen K. Breastfeeding: a smart investment in people and in economies. Lancet. 2016;387(10017):416.
  • Victora CG, Bahl R, Barros AJD, et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–15.
  • Li R, Fein SB, Chen J, et al. Why mothers stop breastfeeding: mothers’ self-reported reasons for stopping during the first year. Pediatrics. 2008;122:S69.
  • Savage J, Johns CB. Food allergy: epidemiology and natural history. Immunol Allergy Clin North Am. 2015;35(1):45–59.
  • Venter C, Arshad SH. Epidemiology of food allergy. Pediatr Clin North Am. 2011;58(2):327–349.
  • Flom DJ, Sicherer HS. Epidemiology of cow’s milk allergy. Nutrients. 2019;11(5):1051.
  • Nwaru BI, Hickstein L, Panesar SS, et al. The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy. 2014;69(1):62–75.
  • Rona RJ, Keil T, Summers C, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immunol. 2007;120(3):638–646.
  • Koletzko S, Niggemann B, Arato A, et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012;55(2):221–229.
  • Walsh J, Meyer R, Shah N, et al. Differentiating milk allergy (IgE and non-IgE mediated) from lactose intolerance: understanding the underlying mechanisms and presentations. Br J Gen Pract. 2016;66(649):e609–e611.
  • Nowak-Wegrzyn A, Chehade M, Groetch ME, et al. International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: executive summary-workgroup report of the adverse reactions to foods committee, american academy of allergy, asthma & immunology. J Allergy Clin Immunol. 2017;139(4):1111–1126 e1114.
  • de Santé HA. Methodological Guidance - Choices in methods for economic evaluation. 2020 Retrieved 23 June 2021. Available from: www.has-sante
  • Berni Canani R, Nocerino R, Terrin G, et al. Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. 2013;163(3):771–777 e771.
  • Berni Canani R, Di Costanzo M, Bedogni G, et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow’s milk allergy: 3-year randomized controlled trial. J Allergy Clin Immunol. 2017;139(6):1906–1913 e1904.
  • Nocerino R, Bedogni G, Carucci L, et al. The impact of formula choice for the management of pediatric cow’s milk allergy on the occurrence of other allergic manifestations: the atopic march cohort study. J Pediatr. 2021;232:183–191.e3.
  • Weill C, Banta D. Development of health technology assessment in France. Int J Technol Assess Health Care. 2009;25(1):108–111.
  • Dubromel A, Geffroy L, Aulagner G, et al. Assessment and diffusion of medical innovations in France: an overview. J Mark Access Health Policy. 2018;6(1):1458575.
  • Iskedjian M, Dupont C, Spieldenner J, et al. Economic evaluation of a 100% whey-based, partially hydrolysed formula in the prevention of atopic dermatitis among French children. Curr Med Res Opin. 2010;26(11):2607–2626.
  • Spieldenner J, Belli D, Dupont C, et al. Partially hydrolysed 100% whey-based infant formula and the prevention of atopic dermatitis: comparative pharmacoeconomic analyses. Ann Nutr Metab. 2011;59(1):44–52.
  • Guest JF, Panca M, Ovcinnikova O, et al. Relative cost-effectiveness of an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Italy. Clinicoecon Outcomes Res. 2015;7:325–336.
  • Guest JF, Weidlich D, Mascunan Diaz JI, et al. Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Spain. Clinicoecon Outcomes Res. 2015;7:583–591.
  • Guest JF, Weidlich D, Kaczmarski M, et al. Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow’s milk allergy in Poland. Clinicoecon Outcomes Res. 2016;8:307–316.
  • Guest JF, Singh H. Cost-effectiveness of using an extensively hydrolyzed casein formula supplemented with Lactobacillus rhamnosus GG in managing IgE-mediated cow’s milk protein allergy in the UK. Curr Med Res Opin. 2019;35(10):1677–1685.
  • Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health. 2013;16(2):e1–5.
  • Edwards C, Younus M. Cow milk allergy. StatPearls Publishing. 2021;2021:1.
  • Dupont C, Bocquet A, Tome D, et al. hydrolyzed rice protein-based formulas, a vegetal alternative in cow’s milk allergy. Nutrients. 2020;12(9):2654.
  • Strozyk A, Horvath A, Meyer R, et al. Efficacy and safety of hydrolyzed formulas for cow’s milk allergy management: a systematic review of randomized controlled trials. Clin Exp Allergy. 2020;50(7):766–779.
  • Mitchell MM, Winchen B, Wilms T, et al. markummitchell/engauge-digitizer: nonrelease. 2022.
  • Martins R, Minshall E, Minshall E. Cost-effectiveness analysis of hypoallergenic milk formulas for the management of cow’s milk protein allergy in the UK. J Health Econ Outcomes Res. 2021;8(2):14–25.
  • L’Assemblée nationale et le Sénat. LOI no 2012-300 du 5 mars 2012 relative aux recherches impliquant la personne humaine. J Off Répub Fr. 2012;2012:56.
  • Amiel P. Comité d’évaluation éthique de l’inserm (CEEI), Guide de qualification des recherches en santé [A qualification guide for health research]. Inserm. 2021;2021:1.
  • Mead J. Formulary decision guide: nutramigen. 2019.
  • Institut National de la Statistique et des Études Économiques (Insee). Indice des prix à la consummation – base 2015 – ensemble des ménages – services de santé. 2021. Retrieved 24 June 2021. Available from: https://www.insee.fr/fr/statistiques/serie/001763845.
  • Française R. Le site officiel de l’administration française: remboursement d’une consultation médicale pour un enfant. 2014.
  • l’Assurance Maladie. Consultations des enfants de moins de 16 ans. 2021. Retrieved 23 June 2021. Available from: https://www.ameli.fr/assure/remboursements/rembourse/consultations/metropole#text_649
  • l’Assurance Maladie. Codage des actes médicaux (CCAM). 2021. Retrieved 23 June 2021. Available from: https://www.ameli.fr/accueil-de-la-ccam/telechargement/version-actuelle/index.php
  • l’ Assurance Maladie. Aide au Codage. 2021 Retrieved 23 June 2021. Available from: https://www.aideaucodage.fr/ccam
  • ScanSanté. Référentiel national de cout des prises en chanrge (ENC). 2021 Retrieved 23 June 2021. Available from: https://www.scansante.fr/applications/enc-mco
  • iQVIA Data on file. Milk formula unit costs and market shares. 2021.
  • Ministère des affaires sociales et de la santé. Avis relatif à la baisse de certains produits et prestations visés à l’article L. 165-1 du code de la securité sociale. J Off Répub Fr. 2016;114.
  • Ministère des solidarités et de la santé. Avis relatif à la tarification des denrées alimentaires destinées à des fins médicales visées à lárticle L. 165-1 du code de la securité sociale. J Off Répub Fr. 2021.
  • Carrefour. 2021. Retrieved 18 June 2021. Available from: https://www.carrefour.fr
  • Comité Economique des Produits de Santé. Prix des Medicaments. 2021. Retrieved 30 June 2021. Available from: http://medicprix.sante.gouv.fr/medicprix/
  • l’Assurance Maladie. Base des Médicaments et Informations Tarifaires. 2021. 18 June 2021. Available from: http://www.codage.ext.cnamts.fr/codif/bdm_it/index.php?p_site=AMELI
  • CNAMTS. Les actes de biologie médicale: analyse des dépenses en 2008 et 2009. Points Rep. 2010;2010:33.
  • Shop Pharmacie. 2021. Retrieved18 June 2021. Available from: https://www.shop-pharmacie.fr
  • Cocooncenter - Parapharmacie en ligne. 2021. Retrieved18 June 2021. Available from: https://www.cocooncenter.com/
  • Pharmacie Veau. Available from: 2021. Retrieved18 June 2021. Available from: https://www.pharmacieveau.fr/
  • DoctiPharma by DocMorris. 2021. Retrieved18 June 2021. Available from: https://www.doctipharma.fr/
  • Ministère des Solidarités et de la Santé. Avis relatif à la tarification des denrées alimentaires destinées à des fins médicales spéciales visées à l’article L. 165-1 du code de la sécurité sociale. J Off Répub Fr. 2021.
  • NICE Decision Support Unit. Technical support document 8: an introduction to measurement and valuation of health for NICE submissions. 2011.
  • Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford, UK: Oxford University Pres; 2006.
  • Hackshaw A. A concise guide to clinical trials. Oxford, UK: John Wiley & Sons; 2011.
  • von Berg A, Filipiak-Pittroff B, Krämer U, et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolyzed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergol Select. 2017;1(1):28–38.
  • von Berg A, Filipiak-Pittroff B, Krämer U, et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol. 2008;121(6):1442–1447.
  • von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol. 2007;119(3):718–725.
  • von Berg A, Koletzko S, Grübl A, et al. The effect of hydrolyzed cow’s milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol. 2003;111(3):533–540.
  • Baldassarre ME, Laforgia N, Fanelli M, et al. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. J Pediatr. 2010;156(3):397–401.
  • Berni Canani R, Nocerino R, Terrin G, et al. Effect of lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol. 2012;129(2):580–582, 582.e581–585.
  • Sánchez-Valverde F, Etayo V, Gil F, et al. Factors associated with the development of immune tolerance in children with cow’s milk allergy. Int Arch Allergy Immunol. 2019;179(4):290–296.